Follow
werner kissling
werner kissling
Verified email at lrz.tum.de
Title
Cited by
Cited by
Year
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ...
The Lancet 382 (9896), 951-962, 2013
25372013
What does the PANSS mean?
S Leucht, JM Kane, W Kissling, J Hamann, E Etschel, RR Engel
Schizophrenia research 79 (2-3), 231-238, 2005
11132005
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A …
S Leucht, G Pitschel-Walz, D Abraham, W Kissling
Schizophrenia research 35 (1), 51-68, 1999
11091999
The effect of family interventions on relapse and rehospitalization in schizophrenia—a meta-analysis
G Pitschel-Walz, S Leucht, J Bäuml, W Kissling, RR Engel
Schizophrenia bulletin 27 (1), 73-92, 2001
9702001
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis
The Lancet 379 (9831), 2063-2071, 2012
9462012
Clinical implications of brief psychiatric rating scale scores
S Leucht, JM Kane, W Kissling, J Hamann, EVA Etschel, R Engel
The British Journal of Psychiatry 187 (4), 366-371, 2005
8152005
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis
C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ...
Schizophrenia research 123 (2-3), 225-233, 2010
7812010
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
S Leucht, K Wahlbeck, J Hamann, W Kissling
The Lancet 361 (9369), 1581-1589, 2003
7462003
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane
American Journal of Psychiatry 160 (7), 1209-1222, 2003
6772003
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
S Leucht, D Arbter, RR Engel, W Kissling, JM Davis
Molecular psychiatry 14 (4), 429-447, 2009
5882009
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation …
S Heres, J Davis, K Maino, E Jetzinger, W Kissling, S Leucht
American Journal of Psychiatry 163 (2), 185-194, 2006
5862006
Oral versus depot antipsychotic drugs for schizophrenia—a critical systematic review and meta-analysis of randomised long-term trials
C Leucht, S Heres, JM Kane, W Kissling, JM Davis, S Leucht
Schizophrenia research 127 (1-3), 83-92, 2011
5042011
Guidelines for depot antipsychotic treatment in schizophrenia
JM Kane, E Aguglia, AC Altamura, JLA Gutierrez, N Brunello, ...
European Neuropsychopharmacology 8 (1), 55-66, 1998
4351998
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
S Leucht, S Hierl, W Kissling, M Dold, JM Davis
The British Journal of Psychiatry 200 (2), 97-106, 2012
4322012
Shared decision making in psychiatry
J Hamann, S Leucht, W Kissling
Acta Psychiatrica Scandinavica 107 (6), 403-409, 2003
3872003
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses
M Huhn, M Tardy, LM Spineli, W Kissling, H Foerstl, G Pitschel-Walz, ...
JAMA psychiatry 71 (6), 706-715, 2014
3752014
Shared decision making for in‐patients with schizophrenia
J Hamann, B Langer, V Winkler, R Busch, R Cohen, S Leucht, W Kissling
Acta Psychiatrica Scandinavica 114 (4), 265-273, 2006
3712006
Amisulpride, an unusual “atypical” antipsychotic: a meta-analysis of randomized controlled trials
S Leucht, G Pitschel-Walz, RR Engel, W Kissling
American Journal of Psychiatry 159 (2), 180-190, 2002
3682002
Risperidone versus other atypical antipsychotics for schizophrenia
K Komossa, C Rummel‐Kluge, S Schwarz, F Schmid, H Hunger, ...
Cochrane Database of Systematic Reviews, 2011
342*2011
Do patients with schizophrenia wish to be involved in decisions about their medical treatment?
J Hamann, R Cohen, S Leucht, R Busch, W Kissling
American Journal of Psychiatry 162 (12), 2382-2384, 2005
3272005
The system can't perform the operation now. Try again later.
Articles 1–20